From the publishers of JADPRO

Metastatic Triple-Negative Breast Cancer Resource Center

Advertisement

Interview With Sheeba Cantanelli, MPAS, PA-C: Metastatic TNBC Treatment Landscape—An Overview

Interview With Anecita Fadol, PhD, FNP-BC, FAANP, FAAN, FHKAN: Cardiotoxicity in Patients with mTNBC: Keys to Assessing and Treating It

Video Interview With Anecita Fadol, PhD, FNP-BC, FAANP, FAAN, FHKAN: Cardiotoxicity in Patients with mTNBC: Role of Tests, Racial Disparities, and SDOHs

Interview with Valerie Shander, MSN, BSN, FNP, RN, AOCNP, CGRA: Clinical Trials and Pressing Clinical Questions in mTNBC

Interview with Valerie Shander, MSN, BSN, FNP, RN, AOCNP, CGRA: Brain Metastases and the APPs Role in Managing it

Interview With Coral Omene, MD, PhD. Key Clinical Data in mTNBC: Updates from SABCS, Part 2

Interview With Coral Omene, MD, PhD. Key Clinical Data in mTNBC: Updates from SABCS, Part 1

Interview With Rose DiMarco, PharmD, BCPS, BCOP. Sequencing of Treatment at the Time of Relapse: A Pharmacist's Perspective

Interview With Mikel Ross, MSN, RN, AGPCNP-BC, OCN, CBCN. Practice-Changing Data in mTNBC: A Post-ASCO Update

Interview With Lindsay Shaw, ANP-BC, AOCNP: Tumor Biology and Risk Assessment in Metastatic TNBC

Treatment of a Patient With AML and mTNBC

Patient With Lung Metastasis and HER2-Low Status: Evolving Treatment Options

Fast Facts #6: Immunotherapy and Endocrinopathies